Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. | CDC RFA CK 26 0221

Frequently Asked Questions (FAQs)

What is CDC RFA CK 26 0221?

CDC RFA CK 26 0221 is a discretionary funding opportunity from the Centers for Disease Control and Prevention (CDC), offered through the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). It focuses on reducing the burden of parasitic infections in the United States by supporting evidence-based prevention and control activities.

What is the main goal of this funding opportunity?

The intent is to strengthen public health efforts that prevent, detect, and control parasitic diseases using strategies supported by data and established best practices, with an emphasis on real-world implementation and measurable impact.

What type of grant mechanism is this?

This opportunity is released as a Cooperative Agreement. That typically means recipients should expect substantial CDC involvement beyond providing funds, such as collaboration on planning, implementation approaches, performance measurement, and dissemination of results.

Which CDC center is sponsoring this opportunity?

The opportunity is offered through CDC's National Center for Emerging and Zoonotic Infectious Diseases (NCEZID).

What is the CFDA number for this opportunity?

The opportunity is listed under CFDA 93.084.

What is the application deadline?

Applications are due by July 17, 2026 (original closing date).

How many awards does CDC expect to make?

CDC anticipates making approximately 11 awards.

What is the maximum funding amount per award?

The award ceiling is $1,250,000 per award.

Is the project period or length of performance provided?

Not in the notice text provided. The information shared does not describe the project period or required work plan components.

Does the opportunity specify which parasites or diseases must be addressed?

Not in the notice text provided. While the framing is about parasitic infections in the United States, specific target parasites are not identified in the information provided.

Who is eligible to apply?

Eligibility is broad and includes government entities, educational institutions, tribal governments and organizations, housing authorities, nonprofits, for-profits, and small businesses, as described in the notice summary.

Which government entities are eligible?

Eligible government applicants include state, county, city or township governments, special district governments, and independent school districts.

Are colleges and universities eligible?

Yes. Public and state-controlled institutions of higher education are eligible, and private institutions of higher education are also eligible.

Are tribal governments and tribal organizations eligible?

Yes. Eligibility includes federally recognized tribal governments and other tribal organizations.

Are housing authorities eligible to apply?

Yes. Public housing authorities and Indian housing authorities are included in the eligibility list.

Are nonprofits eligible, including those without 501(c)(3) status?

Yes. The opportunity is open to nonprofits both with and without 501(c)(3) status (with the note that these nonprofit categories exclude institutions of higher education).

Are for-profit entities eligible?

Yes. For-profit organizations other than small businesses are eligible, and small businesses are also explicitly eligible.

What does "others/unrestricted" eligibility mean here?

The eligibility list includes an "others/unrestricted" category, suggesting the program may be open to additional applicant types beyond those specifically listed in the summary.

Can a bona fide agent apply on behalf of a government entity?

Yes. Bona fide agents are explicitly permitted to apply on behalf of eligible government entities. This allows an authorized organization to submit and manage the grant on behalf of state, territorial, local, or tribal governmental organizations.

Why would an organization use a bona fide agent?

Based on the information provided, this can be important when government entities rely on an external partner for grants management, procurement, staffing, or specialized technical capacity.

What kinds of activities are implied by "evidence-based prevention and control"?

The summary suggests evidence-based work may include improving surveillance and reporting, strengthening laboratory or diagnostic access, expanding screening in appropriate settings, targeted education and risk communication, provider training to reduce missed diagnoses, and interventions that reduce exposure pathways in homes, schools, workplaces, or community environments.

Are clinical partnerships relevant to this opportunity?

Yes. The information provided indicates that prevention and control efforts may include coordination with clinical providers, particularly for screening, diagnosis, addressing barriers to care, or treatment completion strategies.

Are environmental or vector-related approaches potentially relevant?

Yes. Depending on the parasite and setting, the summary notes that work may include vector control or environmental measures and interventions that reduce exposure pathways.

Is outbreak detection and response within scope?

The information provided suggests that, depending on the parasite and setting, activities may include outbreak detection and response support.

What does CDC involvement typically look like in a cooperative agreement?

Based on the description provided, recipients should expect CDC collaboration on planning, implementation approaches, performance measurement, and dissemination of results, rather than CDC only providing funds.

Does this funding emphasize measurable outcomes and evaluation?

Yes. The cooperative agreement structure is described as implying an emphasis on measurable outcomes, performance monitoring, and sharing results so other jurisdictions can replicate successful methods.

What makes an application "strong" based on the description provided?

The summary suggests strong applications will use data to define local burden, identify affected populations, and justify the intervention approach, with strategies grounded in evidence and established best practices.

What is the overall focus area or category for this opportunity?

It is listed under the health funding activity category and focuses specifically on parasitic infections in the United States.

Is this program intended only for government health departments?

No. While many government entities are eligible, the opportunity is also open to higher education institutions, tribal organizations, housing authorities, nonprofits, for-profits, and small businesses, indicating CDC is aiming to fund a mix of public agencies and implementation partners.

What kinds of settings or channels might be involved in implementation?

The summary notes that eligible and relevant partners may reach high-risk populations through clinical, community, housing, education, or environmental health channels.